|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/06 | |
| C07D 401/06 | |||
| C07D 207/416 | |||
| A61K 31/4439 | |||
| A61K 31/4025 | |||
| A61P 3/10 | |||
| A61P 25/28 |
| (11) | Number of the document | 1646626 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04749150.1 |
| Date of filing the European patent application | 2004-07-08 | |
| (97) | Date of publication of the European application | 2006-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2008-07-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2004/001114 |
| Date | 2004-07-08 |
| (87) | Number | WO 2005/005417 |
| Date | 2005-01-20 |
| (30) | Number | Date | Country code |
| 0316232 | 2003-07-11 | GB |
| (72) |
BOSTRÖM, Jonas, SE
BRICKMANN, Kay, SE
HOLM, Patrik, SE
SANDBERG, Pernilla, SE
SWANSON, Marianne, SE
WESTERLUND, Christer, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS |
| PYRROLE-2, 5-DIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS |